Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
-
SciScore for 10.1101/2021.09.17.21263532: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: EXPERIMENTAL MODEL AND SUBJECT DETAILS: Ethics Statement: All work was conducted in accordance with the Declaration of Helsinki in terms of informed consent and approval by an appropriate institutional board.
IRB: The study was approved by the respective Institutional Review Boards (no. 19.381 at CHUM and no. 2020/ST/049 at ASST Santi Paolo et Carlo)Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources For evaluation of anti-SARS-CoV-2 antibody-dependent cellular cytotoxicity (ADCC), parental CEM. anti-SARS-CoV-2suggested: NoneThe detection … SciScore for 10.1101/2021.09.17.21263532: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: EXPERIMENTAL MODEL AND SUBJECT DETAILS: Ethics Statement: All work was conducted in accordance with the Declaration of Helsinki in terms of informed consent and approval by an appropriate institutional board.
IRB: The study was approved by the respective Institutional Review Boards (no. 19.381 at CHUM and no. 2020/ST/049 at ASST Santi Paolo et Carlo)Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources For evaluation of anti-SARS-CoV-2 antibody-dependent cellular cytotoxicity (ADCC), parental CEM. anti-SARS-CoV-2suggested: NoneThe detection of SARS-CoV-2-antigen specific B cells was done by adding the RBD probes to the antibody cocktail (IgM BUV737, CD24 BUV805, IgG BV421, CD3 BV480, CD56 BV480, CD14 BV480, CD16 BV480, CD20 BV711, CD21 BV786 CD24suggested: (BD Biosciences Cat# 742010, RRID:AB_2871308)CD3suggested: NoneCD56suggested: (BD Biosciences Cat# 566162, RRID:AB_2739559)CD14suggested: (BD Biosciences Cat# 566141, RRID:AB_2739539)CD16suggested: (BioLegend Cat# 348805, RRID:AB_2889063)CD20suggested: (BD Biosciences Cat# 743611, RRID:AB_2741622)CD21suggested: (BD Biosciences Cat# 742764, RRID:AB_2741029)Experimental Models: Cell Lines Sentences Resources Cell lines: 293T human embryonic kidney and HOS cells (obtained from ATCC) were maintained at 37°C under 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) (Wisent) containing 5% fetal bovine serum (FBS) (VWR) and 100 μg/ml of penicillin-streptomycin (Wisent). HOSsuggested: None293T-ACE2 cell line was previously reported (Prévost et al., 2020). 293T-ACE2suggested: NoneCell surface staining and flow cytometry analysis: 293T cells were co-transfected with a GFP expressor (pIRES2-GFP, Clontech) in combination with plasmids encoding the full-length Spikes of SARS-CoV-2 variants or Spikes from different Betacoronaviruses. 293Tsuggested: NoneRecombinant DNA Sentences Resources Cell surface staining and flow cytometry analysis: 293T cells were co-transfected with a GFP expressor (pIRES2-GFP, Clontech) in combination with plasmids encoding the full-length Spikes of SARS-CoV-2 variants or Spikes from different Betacoronaviruses. pIRES2-GFPsuggested: NoneVirus neutralization assay: To produce the pseudoviruses, 293T cells were transfected with the lentiviral vector pNL4.3 R-E- Luc (NIH AIDS Reagent Program) and a plasmid encoding for the indicated S glycoprotein (D614G, B.1.1.7, P.1, B.1.351, B.1.617.2, B.1.526 and SARS-CoV) at a ratio of 10:1. pNL4.3suggested: NoneSoftware and Algorithms Sentences Resources All samples were acquired on an LSRII cytometer (BD Biosciences) and data analysis was performed using FlowJo v10.7.1 (Tree Star). FlowJosuggested: (FlowJo, RRID:SCR_008520)Statistics were analyzed using GraphPad Prism version 8.0.1 (GraphPad, San Diego, CA). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Software scripts and visualization: Edge bundling graphs were generated in undirected mode in R and RStudio using ggraph, igraph, tidyverse,and RColorBrewer packages (R; R studio). RStudiosuggested: (RStudio, RRID:SCR_000432)RColorBrewersuggested: (RColorBrewer, RRID:SCR_016697)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a protocol registration statement.
Results from scite Reference Check: We found no unreliable references.
-